Loading
Life sciences · Journal article
Acs Applied Nano Materials · October 22, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Abstract Triple-negative breast cancer (TNBC) therapy faces a paradox: Reactive oxygen species (ROS)-generating nanozyme depletes oxygen (O2) and triggers glutathione (GSH) defense, reducing efficacy in hypoxic tumors. To resolve this problem, we developed an enzyme by coupling glucose oxidase (GOx)-mediated glucose depletion with ROS generation and GSH consumption. Dendritic core−shell PtFe@RuRhMo nanocrystals were synthesized, integrating catalase-, peroxidase-, and glutathione oxidase-like activities, accompanied by functionalization with GOx and doxorubicin (DOX). The nanozyme exhibited a threefold lower Michaelis constant for H2O2 than horseradish peroxidase (Km = 0.186 mM), depleted 95.87% of GSH in a cell-free solution within 15 min, and induced 62.3% apoptosis in 4T1 cells under high-glucose conditions. In vivo, the nanodrug achieved marked tumor suppression in all treated mice while exhibiting minimal toxicity. This design precisely modulates the tumor microenvironment in aggressive cancers. The cascade informs multienzyme-based cancer therapy. Future work will optimize the PEGylation density and evaluate long-term biodistribution in larger animal models.